On Tuesday (May 13), the cohosts of The View chose to talk about Donald Trump ‘s newest executive order pushing for the ...

The White House has set a one-month deadline for drug manufacturers to negotiate lower prices. If they fail to do so, the ...

The Legislature and Gov. Maura Healey last year enacted a pair of new health policy laws, including one aimed at reining in ...

It is somewhat bewildering to watch the Republican Party morph into an economically left-wing party without anyone really ...

LISTEN: Price caps lead to shortages. Want to reduce costs? Allow drug companies to sell directly and eliminate the middlemen ...

Long-threatened tariffs from U.S. President Donald Trump have plunged the country into trade wars abroad — all while on-again ...

While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account ...

The markets have rewarded the Trump administration’s walkbacks, but the president is still a true believer in trade ...

Right now, there is a new push to lower prescription drug prices in the United States. President Donald Trump recently signed an executive order that he claimed could lower drug prices by as much as ...

The President’s proposal, of "most favored nation" (MFN) policy, tying U.S. drug prices to the lowest prices paid by other ...

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...

Shares of key drugmakers like Eli Lilly LLY, Pfizer PFE, Merck MRK, AbbVie ABBV, Gilead, Bristol-Myers, Amgen AMGN and several other U.S. pharmaceutical stocks were in the green at market close on ...